The global market for veterinary anti-infectives is estimated to be worth USD4.52 million in 2016. Expected to grow at a healthy CAGR of 6.35%, the market is set to reach USD 6.15 million by 2021. Global veterinary healthcare offers services and products in various segments such as vaccines, parasiticides, anti-infectives, medicinal feed additives, other pharmaceuticals, out of which anti-infectives are growing at a steady pace to combat the increasing number of infectious diseases in animals. It is the second best segment after vaccines and holds about 20% of the global animal healthcare market share.
Global Veterinary Anti-Infectives Market- Market Dynamics
The report studies various driving and restraining factors for the global veterinary anti-infectives market. Some of these are listed below.
Increased competition for cultivated land and cost-effective production are the major obstacles in the path of global veterinary anti-infectives market.
The report highlights the segment-wise contribution of different anti-incentives by disease, species, and geography. By type of products, the market has been segmented into marbofloxacin, florfenicol, freeze-dried ceftiofur, beta-lactams, oxytetracycline, and aminosidine; by species into companion and farm animals and by geography into North America, Asia-Pacific, Europe and Rest of World.
Some of the key players in the market are:
What the Report Offers